Bienvenue sur Agri Investment Fund

Nouvelles

21.10.20
First vaccine based on ViroVet PLLAV technology enters development

ViroVet nv, a leading Belgian biopharmaceutical company active in the development of innovative vaccines and antiviral drugs for livestock, is proud to announce that it has successfully confirmed the efficacy of its porcine reproductive and respiratory syndrome (PRRS) vaccine based on the PLLAV or plasmid-launched live attentuated virus technology.

10.09.20
Biotalys honored with two AgTech Breakthrough Awards

Recognition of Biotalys' unique protein-based biocontrol solutions for food protection.

Biotaly nv, a transformative food and crop protection company, today announced that it won the "Crop Protection Solution of the Year" and the "Overall Food Quality Solution of the Year" awards in the inaugural AgTech Breakthrough Awards program.

09.07.20
Biotalys appoints Wim Ottevaere as Chief Financial Officer in preparation for global growth

Strenghtening Executive Management Team with international financial leadership

Biotalys nv, a transformative food and crop protection company, today announced the appointment of Wim Ottevaere as Chief Financial Officer.  Wim joins the Executive Management Team and will be based in Ghent.  He will provide strategic financial leadership and will be focused on supporting the organization towards its next financing event.

28.05.20
Seventure Partners entre au capital de ViroVet pour son tour de Série B

Une entreprise de santé animale dédiée à la lutte contre les infections virales en élevage

26.05.20
Biotalys awarded € 1.6 million VLAIO research grant

Funding will enable accelerated development of a proprietary platform for the industrial production of Biotalys' protein-based biocontrols.

Biotalys nv, a transformative food and crop protection company, today announced that it has been rewarded a € 1.6 million research grant from Flanders Innovation & Entrepreneurship (VLAIO).  The grant will run over three years and will support the accelerated development of cost-efficient microbial cell factories for the industrial production of Biotalys' unique new generation protein-based biocontrol solutions.

Previous Pause Suivant